« Tendon Rupture | Main

Tequin Manufacturer Bristol Myers Fined

Bristol-Myers Squibb Co. offered to pay $499 million to settle federal investigations into whether the company played a role in a pricing scheme that led insurers and government agencies to overpay for drugs. The company reduced its profit forecast to reflect the charges.

Posted by Michael Monheit on January 16, 2007 08:38 AM |

TrackBack

TrackBack URL for this entry:
http://blogs.legalview.com/mt-admin/mt-tb.cgi/915

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)